Chad Tang: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Chad Tang

Dr. Chad Tang is an Associate Professor and Radiation Oncologist at MD Anderson Cancer Center in Houston, Texas. His clinical focus is on treating patients with genitourinary cancers, including prostate, kidney, bladder, and testicular cancer, using image-guided radiation therapy (IGRT), proton therapy, stereotactic body radiation therapy (SBRT), and brachytherapy.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Tang will present on “Multidisciplinary Integration in Advanced RCC”. His presentation will highlight:

• The role of radiation therapy as part of a multidisciplinary approach in advanced RCC management.
• Emerging radiation techniques and their integration with systemic therapies to improve patient outcomes.
• Strategies for optimizing clinical decision-making through team-based care in advanced kidney cancers.
• Enhancing quality of life and survival through coordinated, personalized treatment plans.

Drawing from his extensive clinical experience and research, Dr. Tang emphasizes a collaborative, patient-centered approach to radiation oncology within the broader multidisciplinary care framework for advanced RCC.

Global Voices in Renal Oncology (VIRO) 2025